Oxbridge Re Holdings Reports Second Quarter 2016 Results

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
Oxbridge Re Holdings Reports Second Quarter 2016 Results and Declares Quarterly Dividend

GRAND CAYMAN, CAYMAN ISLANDS--(Marketwired - Aug 15, 2016) - Oxbridge Re Holdings Limited ( NASDAQ : OXBR ), a provider of reinsurance solutions to property and casualty insurers in the Gulf Coast region of the United States, reported financial results for the second quarter ended June 30, 2016.

Second Quarter 2016 Results Net income totaled $872,000 or $0.14 per basic and diluted common share compared with $1.7 million or $0.27 per basic and diluted common share in the second quarter of 2015. The decrease was primarily due to the recording of loss and loss adjustment expenses partially offset by the recognition of additional premiums via the change in loss experience refund payable [see comment below] during the second quarter of 2016, coupled with lower investment income earned during the second quarter of 2016.

A component of net premiums earned is the change in loss experience refund payable. This quarter, the change in loss experience refund payable decreased by approximately $1.8 million during the second quarter of 2016 due to a loss suffered under one of our retrospectively rated contracts. Under such contracts, the Company recognizes additional premiums should a loss event occur under the contract. The effect of this decrease in the change in loss experience refund payable resulted in net premiums earned increasing 105% to $3.3 million. Net premiums earned are not expected to remain at this level and should normalize in future quarters, unless further losses are suffered under our retrospectively rated contracts.

Net investment income totaled $109,000 coupled with $77,000 of net realized investment gains. This compares with $96,000 of net investment income coupled with $333,000 of net realized investment gains for the second quarter of 2015.

Total expenses, including losses and loss adjustment expenses, policy acquisition costs and underwriting expenses, and general and administrative expenses, were $2.7 million compared with $408,000 in the second quarter of 2015. The increase was driven by the establishment of $2.2 million in reserves for loss and loss adjustment expenses.

During the second quarter of 2016 the company repurchased 11,530 common shares under the $2.0 million share repurchase plan approved by the board of directors in May 2016. These shares were repurchased at an average price of $5.22 per share.

Dividends paid per share were $0.12 for the second quarter of 2016, unchanged from the second quarter of 2015.

At June 30, 2016, cash and cash equivalents, and restricted cash and cash equivalents, totaled $35.2 million compared with $39.0 million at December 31, 2015.

Second Quarter 2016 Financial Ratios Loss ratio, which measures underwriting profitability, is the ratio of losses and loss adjustment expenses incurred to net premiums earned. The loss ratio was 66.2% for the second quarter of 2016 compared to 0.0% for the second quarter of 2015. The increase is wholly due to the establishment of a reserve for loss and loss adjustment expenses during the second quarter of 2016.

Acquisition cost ratio, which measures operational efficiency, compares policy acquisition costs and other underwriting expenses to net premiums earned. The acquisition cost ratio was 2.0% for the second quarter of 2016 compared with 5.3% for the same year-ago period. The decrease was due to lower average acquisition costs on reinsurance contracts coupled with higher net premiums earned during the second quarter of 2016 as a result of the positive change in loss experience refund payable component.

Expense ratio, which measures operating performance, compares policy acquisition costs, other underwriting expenses and general and administrative expenses to net premiums earned. The expense ratio totaled 13.3% during the second quarter of 2016 compared with 24.9% for the second quarter of 2015. The decrease resulted from higher net premiums earned due to derecognition of loss experience refund reserves during the second quarter of 2016.

Combined ratio, which is used to measure underwriting performance, is the sum of the loss ratio and the expense ratio. If the combined ratio is at or above 100%, underwriting is not profitable. The combined ratio totaled 79.5% for the second quarter of 2016 and 24.9% for the second quarter of 2015.

Six Months Ended June 30, 2016 Financial Results Net premium earned totaled $4.7 million compared with $3.2 million for the first six months of 2015. The increase was driven by the recognition of approximately $1.8 million of additional premiums via the change in loss experience refund payable [see comment above] during the first six months of 2016.

Net investment income totaled $203,000 coupled with net realized investment gains of $133,000. This compares with $172,000 of net investment income coupled with $976,000 of net realized investment gains for the first six months of 2015.

Total expenses, including losses and loss adjustment expenses, policy acquisition costs and underwriting expenses, and general and administrative expenses, were $3.1 million compared with $845,000 in the first six months of 2015. The increase was driven by the establishment of reserves for loss and loss adjustment expenses reported under one of the company's contracts as well as the payment of losses occurring under a separate contract during the first six months of 2016.

Net income totaled $1.9 million or $0.32 per basic and diluted common share compared with net income of $3.5 million or $0.58 per basic and diluted common share in the same year-ago period. The decrease in net income was primarily driven by the loss and loss adjustment expenses during the six months ended June 30, 2016, coupled with lower investment income earned during the first six month of 2016.

Dividends paid per share were $0.24 for the six months ended June 30, 2016, unchanged from the same year-ago period.

Six Months Ended June 30, 2016 Financial Ratios The loss ratio was 48.2% compared to no losses and a loss ratio of 0.0% during the first six months of 2015.

The acquisition cost ratio was 2.7% compared with 5.5% for the year-ago period. The decrease was due to lower average acquisition costs on reinsurance contracts coupled with higher net premiums earned during the first six months of 2016 as a result of the positive change in loss experience refund payable component.

The expense ratio was 18.4% compared with 26.5% for the first six months of 2015. The decrease is as a result of higher net premiums earned due to derecognition of loss experience refund reserves mentioned above. There is also no correlation between such adjustment to net premiums earned and changes in general and administrative expenses.

The combined ratio was 66.6% compared with 26.5% for the year-ago period.

Management Commentary "Despite experiencing a loss, we still had a profitable quarter. Additionally, we demonstrated our commitment to our shareholders by implementing a $2 million share repurchase program and repurchasing shares during the quarter," said Oxbridge Re Holdings President and CEO Jay Madhu . "As we look forward, we are confident our book of diversified business is well positioned for the remainder of 2016."

Subsequent Events Subsequent to the quarter end, the company recently declared its regular quarterly cash dividend in the amount of 12 cents. The dividend will be paid on September 30, 2016 to shareholders of record on the close of business September 23, 2016.

Conference Call Management will host a conference call later today to discuss these financial results, followed by a question and answer session. President and CEO Jay Madhu, and Financial Controller Wrendon Timothy will host the call starting at 4:30 p.m. Eastern time.

The live presentation can be accessed by dialing the number below or by clicking the webcast link available on the Investor Information section of the company's website at www.oxbridgere.com .

Date: Monday, August 15, 2016 Time: 4:30 p.m. Eastern time Listen-only toll-free number: 877-407-0782 Listen-only international number: 201-689-8567 Conference ID: 13642405

Please call the conference telephone number 10 minutes before the start time. An operator will register your name and organization. If you have any difficulty connecting with the conference call, please contact Precision IR at 919-481-4000 or operations@issuerdirect.com .

A replay of the call will be available by telephone after 8:00 p.m. Eastern time on the same day of the call and via the Investor Information section of Oxbridge's website at www.oxbridgere.com until September 15, 2016.

Toll-free replay number: 877-660-6853 International replay number: 201-612-7415 Conference ID: 13642405

About Oxbridge Re Holdings Limited Oxbridge ( www.oxbridgere.com ) is a Cayman Islands exempted company that was organized in April 2013 to provide reinsurance business solutions primarily to property and casualty insurers in the Gulf Coast region of the United States. Through Oxbridge's licensed reinsurance subsidiary, Oxbridge Reinsurance Limited, it writes fully collateralized policies to cover property losses from specified catastrophes. Oxbridge specializes in underwriting medium frequency, high severity risks, where it believes sufficient data exists to analyze effectively the risk/return profile of reinsurance contracts. The company's ordinary shares and warrants trade on the NASDAQ Capital Market under the symbols " OXBR " and " OXBRW ," respectively.

Forward-Looking Statements This press release may contain forward-looking statements made pursuant to the Private Securities Litigation Reform Act of 1995. Words such as "anticipate," "estimate," "expect," "intend," "plan," "project" and other similar words and expressions are intended to signify forward-looking statements. Forward-looking statements are not guarantees of future results and conditions but rather are subject to various risks and uncertainties. Some of these risks and uncertainties are identified in the Company's filings with the SEC. The occurrence of any of these risks and uncertainties could have a material adverse effect on the Company's business, financial condition and results of operations. Any forward-looking statements made in this press release speak only as of the date of this press release and, except as required by law, the Company undertakes no obligation to update any forward-looking statement contained in this press release, even if the Company's expectations or any related events, conditions or circumstances change.

Company Contact: Oxbridge Re Holdings Limited Jay Madhu, CEO 345-749-7570 jmadhu@oxbridgere.com

Media contact: Suzie Boland RFB Communications Group 813-259-0345 sboland@rfbcommunications.com

-Tables to follow-

   
OXBRIDGE RE HOLDINGS LIMITED AND SUBSIDIARY  
Consolidated Balance Sheets  
(expressed in thousands of U.S. Dollars, except per share and share amounts)  
           
     
  At June 30, 2016     At December 31, 2015  
  (Unaudited)        
Assets            
Investments:            
Fixed-maturity securities, available for sale, at fair value (amortized cost: $6,081 and $3,080, respectively) $ 6,099     3,096  
Equity securities, available for sale, at fair value (cost: $8,274 and $7,742, respectively)   7,624     6,252  
    Total investments   13,723     9,348  
Cash and cash equivalents   4,658     8,584  
Restricted cash and cash equivalents   30,562     30,368  
Accrued interest and dividend receivable   56     25  
Premiums receivable   9,606     4,117  
Deferred policy acquisition costs   245     90  
Prepayment and other receivables   130     91  
Property and equipment, net   55     64  
    Total assets $ 59,035     52,687  
             
Liabilities and Shareholders' Equity            
Liabilities:            
  Reserve for losses and loss adjustment expenses $ 2,250     -  
  Loss experience refund payable   4,729     9,913  
  Unearned premiums reserve   13,533     5,571  
  Accounts payable and other liabilities   193     176  
    Total liabilities   20,705     15,660  
             
Shareholders' equity:            
  Ordinary share capital, (par value $0.001, 50,000,000 shares authorized; 6,048,470 and 6,060,000 shares issued and outstanding at June 30, 2016 and December 31, 2015, respectively)   6     6  
  Additional paid-in capital   33,657     33,657  
  Retained earnings   5,298     4,838  
  Accumulated other comprehensive loss   (631 )   (1,474 )
      Total shareholders' equity   38,330     37,027  
      Total liabilities and shareholders' equity $ 59,035     52,687  
             
             
OXBRIDGE RE HOLDINGS LIMITED AND SUBSIDIARY
Consolidated Statements of Income (unaudited)
(expressed in thousands of U.S. Dollars, except per share and share amounts)
               
  Three Months Ended   Six Months Ended
  June 30,   June 30,
  2016   2015   2016   2015
  (Unaudited)   (Unaudited)
                   
Revenue                  
Assumed premiums $ 14,562   14,288   $ 15,065   14,888
Change in loss experience refund payable   (288)   (2,065)     (2,377)   (4,116)
Change in unearned premiums reserve   (10,927)   (10,587)     (7,961)   (7,588)
                   
    Net premiums earned   3,347   1,636     4,727   3,184
    Net realized investment gains   77   333     133   976
    Net investment income   108   96     203   172
                   
  Total revenue   3,532   2,065     5,063   4,332
                   
Expenses                  
Losses and loss adjustment expenses   2,215   -     2,278   -
Policy acquisition costs and underwriting expenses   68   87     129   174
General and administrative expenses   377   321     741   671
                   
  Total expenses   2,660   408     3,148   845
                   
  Net income $ 872   1,657   $ 1,915   3,487
                   
                   
Earnings per share                  
Basic and Diluted $ 0.14   0.27   $ 0.32   0.58
                   
                   
Dividends paid per share $ 0.12   0.12   $ 0.24   0.24
                   
                   
                   
Performance ratios to net premiums earned:                  
Loss ratio   66.2%   0.0%     48.2%   0.0%
Acquisition cost ratio   2.0%   5.3%     2.7%   5.5%
Expense ratio   13.3%   24.9%     18.4%   26.5%
Combined ratio   79.5%   24.9%     66.6%   26.5%
                   

Company Contact: Oxbridge Re Holdings Limited Jay Madhu CEO 345-749-7570 jmadhu@oxbridgere.com Media contact: Suzie Boland RFB Communications Group 813-259-0345 sboland@rfbcommunications.com

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Class Action Greenlighted Against Concordia for Title IX Violations

Updated Category News Views 87

Paving the Way for Equality in Campus Sports Ah, courts and colleges—two institutions you'd hope would play by the rules. But here we are, knee-deep in a legal battle with Concordia University Irvine (CUI) caught in the crosshairs of Title IX compliance issues. No surprise there when a federal court finally gave the nod for a class action to plow ahead. Class Action...

Continue Reading
AppLovin Legal Woes: A Deep Dive into Investor Claims

Updated Category News Views 104

AppLovin Faces Legal Heat and Market Scrutiny Bitter truth has a way of crashing like a wave, and AppLovin (NASDAQ: APP) is feeling the brunt of it. Now knee-deep in a securities class action, the firm’s been accused of selling fairy tales about its AI capabilities, leaving investors clutching at substantial losses. If you’ve been banking on their promises between...

Continue Reading
Microsoft's Cloud Misstep: Recovery Plans in Focus

Updated Category News Views 149

Microsoft's Stumble Puts CIOs on Alert Thursday's Microsoft 365 outage, a wrench in the works for every firm that ties its daily operations to these cloud services, has brought some harsh truths to the table. On November 12, outages hit users hard, preventing access to Exchange Online mailboxes and sending ripples through Teams, SharePoint, Copilot, and Defender. You...

Continue Reading
EFICYENT Ventures to Connect at Singapore FinTech Fest

Updated Category News Views 118

Why the Singapore FinTech Festival Matters The world's hardly a stranger to hype, but the Singapore FinTech Festival carries some real weight. From November 18 to 20, 2026, this gig isn't just industry chatter—it's a high-stakes convergence of policymakers, financial institutions, fintech innovators like EFICYENT, and the money folk looking to mold the future of...

Continue Reading
Innovent's Seven Drugs Leap onto 2026 Reimbursement Chart

Updated Category News Views 202

A Bold Move in Biopharmaceuticals Innovent Biologics just pulled a rabbit out of their hat. Seven of their cutting-edge meds made it onto China's National Reimbursement Drug List for 2026. This isn't just a spreadsheet entry—it's a lifeline thrown to patients across the oncology, metabolic, and autoimmune landscapes, as well as a financial booster for Innovent (HKEX:...

Continue Reading
Novo's CagriSema Trial Shows Promising Obesity Results

Updated Category News Views 162

Novo's Latest Weight Loss Gamble Well, look what we have here. Novo Nordisk is shaking up the obesity treatment scene with some bold numbers from their REDEFINE 9 trial. The investigational CagriSema combo of amylin analog and GLP-1 receptor agonist has churned out an eyeball-popping near 21% weight loss. For context, we're staring down the barrel of numbers far meatier...

Continue Reading
Novo's Research Unlocks New Insights into Food Noise

Updated Category News Views 179

Unpacking the Science Behind Food Noise When folks think about losing weight, most picture shedding pounds and fitting into those elusive smaller jeans. But get this—there’s a curveball called ‘food noise’ that’s making waves in obesity treatment. Novo Nordisk’s semaglutide injections are shaking things up, cutting down on those persistent thoughts about food....

Continue Reading
Maritime Safety Urged After New Orleans Vessel Incident

Updated Category News Views 109

The Mississippi River saw a bit of drama near the Port of New Orleans when a river cruise turned into an unexpected rescue operation. Listen up, because incidents like this bring maritime safety right to the forefront; we can't ignore the waters that shape our daily lives here in the Big Easy. Navigating the Waters Safely Some 150 souls found themselves in a pickle when...

Continue Reading
Windward Bio Surges 68% in Nasdaq Debut

Updated Category News Views 134

Windward Bio's Impressive Nasdaq Debut Well, how's that for a debut? Windward Bio, this buzzing clinical-stage biotechnology firm, hit Nasdaq like a storm on November 13, 2026. They priced their IPO at $17.00 per share, but by market close, the stock sat comfortably at $28.50. That's a hearty 68% jump on day one, putting their market value at a sweet $1.69 billion. Behind...

Continue Reading
Ecopetrol Sidesteps Hefty Fines After Investigation Closure

Updated Category News Views 145

Colombian Watchdog Gives Ecopetrol a Pass It's like dodging a bullet in a duel at high noon. The Superintendency of Industry and Commerce (SIC) has finally closed its investigation into Ecopetrol S.A. and its subsidiaries, CENIT and OCENSA, after a probe two years in the making. The stakes were sky-high, folks. We're talkin' about just shy of 530 billion Colombian pesos...

Continue Reading

Top 5 Most Recently Viewed Articles

Kimbell Royalty Partners Engages Investors at Key Conferences

Updated Category News Views 101

Kimbell Royalty Partners to Attend Notable Investor Conferences Kimbell Royalty Partners, LP (NYSE: KRP) is a prominent owner of oil and natural gas mineral and royalty interests. The company proudly manages over 129,000 gross wells across multiple states. In an effort to strengthen investor relations and share its strategic outlook, Kimbell has announced its...

Continue Reading
Karsan's Autonomous Bus Debuts at Efteling Park

Updated Category News Views 72

A Leap Towards Autonomous Mobility What we have here is Karsan breaking new ground again. They've rolled out their Autonomous e-ATAK at Efteling, the famous theme park in the Netherlands. And that's not just any park—it's a place teeming with tourists, a hotspot demanding efficient transport. Yet, these folks aren't just cranking out fancy gadgets for showing off....

Continue Reading
EyePoint Pharmaceuticals Expands Workforce with Stock Options

Updated Category News Views 301

EyePoint Pharmaceuticals Expands Workforce with Stock Options EyePoint Pharmaceuticals, Inc. (Nasdaq: EYPT), a dynamic biopharmaceutical company, is on a mission to enhance the lives of patients facing serious retinal diseases. Recently, the company made a notable announcement regarding the expansion of its team through the granting of non-statutory stock options to new...

Continue Reading
IonQ Shares: Insights Into Their Current Market Performance

Updated Category News Views 204

Overview of IonQ's Current Stock Performance IonQ Inc. IONQ shares have seen a notable decline recently, continuing a downward trend that’s persisted over the last couple of weeks. As the company gears up to announce its second-quarter earnings, investors are closely monitoring the developments, particularly the anticipated shift in stock momentum. Market Sentiment and...

Continue Reading
Exploring the Promising CD47 Inhibitor Drug Market Growth

Updated Category News Views 40

Understanding the CD47 Inhibitor Drug Market Gaining insights into the CD47 inhibitor drug market is crucial for recognizing the changes and advancements in cancer immunotherapy. These drugs play a vital role in the battle against cancer by harnessing the body's immune system to identify and eliminate malignant cells. CD47's Role in Cancer CD47, often referred to as the...

Continue Reading